Latest News

Date Title Topic
27 Mar 2014 ELCC 2014 News: QoL in ENSURE Study of First-Line Erlotinib vs. Gemcitabine/Cisplatin in Asian Patients with EGFR Mutation-Positive NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: Phase I Study of CO-1686 in Patients with EGFR Mutated Recurrent, Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Mar 2014 ELCC 2014 Press Release: Immunotherapy Data Heralds New Era of Lung Cancer Treatment Lung and other thoracic tumours - Immuno-oncology
ESMO Booth
24 Mar 2014 EMA Recommends Granting a Conditional Marketing Authorisation for Vintafolide for the Treatment of Platinum-resistant Ovarian Cancer that Expresses the Folate Receptor Personalised medicine - Gynaecologic malignancies - Anticancer agents & Biologic therapy
20 Mar 2014 Precision Oncology 3.0 Personalised medicine
20 Mar 2014 Coordinating Action Systems Medicine: Systems Biology Application Across Europe Personalised medicine
19 Mar 2014 Idelalisib in Relapsed Indolent Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
18 Mar 2014 2013: A Year of Progress in Oncology Breast cancer - Melanoma - Lung and other thoracic tumours - Gynaecologic malignancies - Gastrointestinal cancers - Anticancer agents & Biologic therapy
17 Mar 2014 Managing the Side Effects of Novel Cancer Immunotherapeutics Immuno-oncology
13 Mar 2014 Screening for Breast Cancer Results in Increased Diagnoses of Early Stage Cancer Breast cancer - Cancer prevention
12 Mar 2014 Long-term Follow-up Shows Continued Benefit of Radical Prostatectomy for Localised Prostate Cancer Genitourinary cancers
11 Mar 2014 Impact of Nivolumab on Survival, Tumour Remission and Long-Term Safety in Patients With Advanced Melanoma Melanoma - Immuno-oncology